Belpointe Asset Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-104
| Closed | -$260 | – | 3782 |
|
|
2022
Q4 | $260 | Buy |
+104
| New | +$260 | ﹤0.01% | 3612 |
|
|
2021
Q1 | – | Sell |
-7,871
| Closed | -$166K | – | 1032 |
|
|
2020
Q4 | $166K | Sell |
7,871
-6,429
| -45% | -$136K | 0.01% | 765 |
|
|
2020
Q3 | $212K | Hold |
14,300
| – | – | 0.02% | 527 |
|
|
2020
Q2 | $210K | Buy |
14,300
+1,100
| +8% | +$16.2K | 0.03% | 514 |
|
|
2020
Q1 | $155K | Sell |
13,200
-2,600
| -16% | -$30.5K | 0.03% | 488 |
|
|
2019
Q4 | $371K | Hold |
15,800
| – | – | 0.05% | 391 |
|
|
2019
Q3 | $292K | Buy |
15,800
+2,407
| +18% | +$44.5K | 0.05% | 392 |
|
|
2019
Q2 | $249K | Buy |
13,393
+193
| +1% | +$3.59K | 0.05% | 364 |
|
|
2019
Q1 | $323K | Buy |
+13,200
| New | +$323K | 0.06% | 233 |
|